SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060498
Filing Date
2022-12-09
Accepted
2022-12-09 16:30:38
Documents
2
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3859
2 POA DOCUMENT poa.txt EX-24 3356
  Complete submission text file 0001209191-22-060498.txt   8807
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ARCA BIOPHARMA, INC. 10170 CHURCH RANCH WAY, STE 100 WESTMINSTER CO 80021
Business Address
Keuer Thomas A (Reporting) CIK: 0001290482 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 221455185